Table 1. Inclusion and exclusion criteria.

	Inclusion	Exclusion
Population	Humans	Non-humans
Intervention	Point of care or rapid tests Tests for combined genital chlamydia and gonorrhoea detection. Implemented as routine practice	Tests that are not classed as point of care or rapid Tests that are not nucleic acid amplification tests Tests for infections other than genital chlamydia and gonorrhoea Tests that only detect chlamydia OR gonorrhoea Tests that are not Conformité Européene (CE)- or Food and Drug Association (FDA)- approved Tests not implemented as routine practice, e.g. implemented as a research-only tool
Outcome	Evaluation of the implementation of the test as in routine practice (e.g. time to treatment)	Research-only outcome (e.g. sensitivity and specificity; modelling of hypothetical scenarios)
Type of study	Peer-reviewed primary research Conference/poster abstracts	Grey literature Review articles Any other type of literature
Date	Articles published up to 16/02/21	Articles published after 16/02/21
Language	Any	Any